← All tickers

Is TXG Worth Buying in 2026?

10x Genomics, Inc. Class A Common Stock

STOCK LABORATORY ANALYTICAL INSTRUMENTS Updated 2026-08-23

Here’s whether 10x Genomics, Inc. Class A Common Stock (TXG) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+14.98% over 10 days); strong 1-year return of +397.1%; 3-month momentum positive (+175.0%). Concerns: RSI 77 — overbought, elevated pullback risk. Currently 0.5% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

TXG is in a confirmed uptrend, trading above both its 50-day ($44.77) and 200-day ($26.56) moving averages. With an RSI of 77.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +397.1% compares to +20.5% for SPY (beat the market by 376.6%).

$10,000 invested 1 year ago → $49,710 today
vs. S&P 500 (SPY) — same period beat market by 376.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($26.56)
✓Above 50-day MA ($44.77)
!RSI(14) neutral zone (30–70) — currently 77.3
✓Positive return (+397.1%)
✓Within 10% of period high (−0.5%)
Period Range $65.12
$11.16 $65.47
RSI (14) 77.3
0 · OversoldOverbought · 100

Key Metrics

Price$65.12
Period Return+397.1%
Period High$65.47
Period Low$11.16
Drawdown−0.5%
MA-50$44.77
MA-200$26.56
RSI (14)77.3
Avg Volume (30d)3.1M
vs. SPYbeat by 376.6%
Return Rank#21 of 999

Trade TXG

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers